Atrial Fibrillation Feasibility Certoparin Trial - AFFECT

Clinical trial NCT00171769 · COMPLETED

Trial details

NCT number: NCT00171769
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Persistent Nonvalvular Atrial Fibrillation

Start date: 2005-04-01
Primary completion: 2006-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.